🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the makers of acetaminophen, claiming the firms concealed potential risks that the medication posed to pediatric brain development.

This legal action comes thirty days after Former President Trump publicized an unproven link between consuming Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in children.

The attorney general is filing suit against the pharmaceutical giant, which once produced the medication, the only pain reliever approved for women during pregnancy, and Kenvue, which presently makes it.

In a official comment, he stated they "betrayed America by gaining financially from pain and pushing pills regardless of the potential hazards."

The manufacturer asserts there is insufficient reliable data linking Tylenol to autism.

"These companies deceived for years, deliberately risking countless individuals to boost earnings," Paxton, a Republican, declared.

Kenvue stated officially that it was "seriously troubled by the spread of false claims on the safety of paracetamol and the likely effects that could have on the health of American women and children."

On its website, Kenvue also stated it had "continuously evaluated the pertinent research and there is insufficient valid information that shows a established connection between using acetaminophen and autism."

Groups acting on behalf of physicians and healthcare providers agree.

ACOG has said acetaminophen - the primary component in Tylenol - is among limited choices for pregnant women to address pain and elevated temperature, which can present major wellness concerns if ignored.

"In more than two decades of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the usage of paracetamol in any period of gestation results in neurological conditions in children," the association said.

The lawsuit cites current declarations from the previous government in claiming the drug is allegedly unsafe.

Recently, the former president raised alarms from public health officials when he advised expectant mothers to "struggle intensely" not to consume acetaminophen when unwell.

The FDA then published an announcement that doctors should contemplate reducing the consumption of Tylenol, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in minors has not been established.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in April to undertake "comprehensive study program" that would establish the source of autism spectrum disorder in a matter of months.

But authorities advised that finding a single cause of autism - believed by scientists to be the outcome of a complex mix of genetic and environmental factors - would not be simple.

Autism is a form of permanent neurological difference and disability that affects how individuals perceive and engage with the environment, and is identified using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is seeking federal office - claims the manufacturer and J&J "deliberately disregarded and tried to quiet the science" around acetaminophen and autism.

This legal action aims to force the firms "eliminate any marketing or advertising" that asserts acetaminophen is secure for pregnant women.

The court case parallels the grievances of a collection of mothers and fathers of minors with autism and ADHD who took legal action against the producers of acetaminophen in recently.

Judicial authorities threw out the case, declaring investigations from the family's specialists was inconclusive.